According to the Center for Disease Control and Prevention, over 37 million people in the U.S. have diabetes. That’s a little over 11% of the entire population.
When you have diabetes your body doesn’t make enough or any insulin at all. Those with the disease must regularly monitor blood sugar. This has been traditionally done with glucometer’s by pricking your finger over and over again for drops of blood. But over the last decade, technology like continuous glucose monitoring have been on the rise.
Abbott and Dexcom are the two most dominant players in the space. Both companies have seen increased growth.
The benefits of this technology are also being marketed by several health and wellness apps as many companies see benefits to those who don’t have diabetes.
CNBC spoke with both Abbott and Dexcom about the technology inside CGMs and how they see it expanding.
Chapters:
00:00 — Introduction
03:08 — Diabetes and Continuous Glucose Monitors
04:36 — Dexcom and Abbott
06:25 — Expansion
10:30 — Competition
14:00 — The future
Produced, Shot and Edited by: Erin Black
Animation: Jason Reginato, Alex Wood
Supervising Producer: Jeniece Pettitt
Additional Camera: Andrew Evers, Sydney Boyo
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
About CNBC: From ‘Wall Street’ to ‘Main Street’ to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
How Dexcom And Abbott Are Moving Beyond Diabetes
